SCHEMBL16607225

SCHEMBL16607225

COc1ccc(F)cc1-c1csc(NC(=O)c2ccc(NC(C)=O)cc2)n1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.73
▸ MEN1 O00255 6/20 0.73
▸ NPC1 O15118 1/20 0.73
▸ KDM4E B2RXH2 7/20 0.55
▸ MAPT P10636 6/20 0.55
▸ MAPK1 P28482 3/20 0.55
▸ ALDH1A1 P00352 5/20 0.55
▸ HTT P42858 2/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ MPL P40238 3/20 0.54
▸ PHGDH O43175 2/20 0.54
▸ PLA2G1B P04054 1/20 0.52
▸ ATG4B Q9Y4P1 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ ADORA2A P29274 1/20 0.51
▸ ADORA2B P29275 1/20 0.51
▸ ADORA1 P30542 1/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16607144 0.89 KMT2A (0.78) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL16607169 0.88 MAPT (0.67) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL16607316 0.88 HTT (0.62) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL16607223 0.82 MEN1 (0.77) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL16607179 0.81 KMT2A (0.69) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL16607221 0.80 KMT2A (0.63) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL16607212 0.79 MEN1 (0.67) KMT2AMEN1KDM4EMAPTMAPK1
SCHEMBL16607168 0.78 MAPT (0.62) KMT2AMEN1KDM4EMAPTMAPK1
SCHEMBL24107407 0.77 KMT2A (0.72) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL16607129 0.77 ADORA3 (0.75) KMT2AMEN1NPC1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-08-04 — — US disclosed
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2019-04-23 — — US disclosed
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-09-15 — — US disclosed
US-9364472-B2 Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof NEW YORK UNIVERSITY (US) 2016-06-14 — — US disclosed
US-9353078-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof NEW YORK UNIVERSITY (US) 2016-05-31 — — US disclosed
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-04-14 — — US disclosed
WO-2015050984-A1 AMINO, AMIDO, AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2015-04-09 — — WO disclosed
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2015-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 KMT2A 4609/4885MEN1 2624/4885NPC1 4220/4885
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof AGER, IAPP, GPR119 KMT2A 4609/4885MEN1 2624/4885NPC1 4220/4885
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 KMT2A 4609/4885MEN1 2624/4885NPC1 4220/4885
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 KMT2A 4609/4885MEN1 2624/4885NPC1 4220/4885
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof AGER, IAPP, GPR119 KMT2A 4609/4885MEN1 2624/4885NPC1 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback